MOH MOLINA HEALTHCARE, INC.
Hospital & Medical Service Plans · NYSE · SEC CIK 1179929 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.9%
TTM net income YoY-105.4%
TTM EPS YoY-104.2%
Revenue 3-yr CAGR9.9%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin0.4%
Net margin-0.1%
FCF margin0.5%
EBITDA margin0.8%
Returns
ROE-1.2%
ROA-0.3%
ROIC (approx.)3.8%
Asset turnover2.82x
Leverage & solvency
Liabilities / assets73.5%
Debt / equity0.91x
Current ratio1.69x
Interest coverage0.81x
Cash quality & payout
Operating cash flow / net income-6.90x
Accruals ratio-2.4%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B |
| Cost of revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B |
| SG&A expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B |
| Operating income | $781.00M | $1.71B | $1.57B | $1.17B | $1.02B |
| Interest expense | $192.00M | $118.00M | $109.00M | $110.00M | $120.00M |
| Pretax income | $589.00M | $1.59B | $1.46B | $1.06B | $875.00M |
| Income tax | $117.00M | $410.00M | $373.00M | $271.00M | $216.00M |
| Net income | $472.00M | $1.18B | $1.09B | $792.00M | $659.00M |
| EBITDA | $976.00M | $1.89B | $1.74B | $1.35B | $1.15B |
| EPS (basic) | 8.93 | 20.52 | 18.91 | 13.72 | 11.40 |
| EPS (diluted) | 8.92 | 20.42 | 18.77 | 13.55 | 11.25 |
| Weighted avg. shares (diluted) | 52.90M | 57.70M | 58.10M | 58.50M | 58.60M |
| Balance sheet | |||||
| Cash & equivalents | $4.25B | $4.74B | $4.85B | $4.05B | $4.51B |
| Short-term investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B |
| Receivables | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B |
| Current assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B |
| PP&E, net | $301.00M | $288.00M | $270.00M | $259.00M | $396.00M |
| Goodwill | $1.96B | $1.67B | $1.24B | $1.11B | $982.00M |
| Intangibles | $237.00M | $267.00M | $208.00M | $275.00M | $270.00M |
| Total assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B |
| Current liabilities | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B |
| Long-term debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B |
| Total debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B |
| Total liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B |
| Shareholders' equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B |
| Net debt | -$482.00M | -$1.82B | -$2.67B | -$1.87B | -$2.33B |
| Shares outstanding | 51.00M | 56.00M | 58.00M | 58.00M | 58.00M |
| Cash flow statement | |||||
| Operating cash flow | -$535.00M | $644.00M | $1.66B | $773.00M | $2.12B |
| Capital expenditure | $101.00M | $100.00M | $84.00M | $91.00M | $77.00M |
| Free cash flow | -$636.00M | $544.00M | $1.58B | $682.00M | $2.04B |
| Investing cash flow | $312.00M | -$464.00M | -$744.00M | -$790.00M | -$1.65B |
| Financing cash flow | -$170.00M | -$347.00M | -$58.00M | -$441.00M | -$183.00M |
| Depreciation & amortization | $195.00M | $186.00M | $171.00M | $176.00M | $131.00M |
| Stock-based compensation | $47.00M | $116.00M | $115.00M | $103.00M | $72.00M |
| Share buybacks | $1.00B | $1.00B | $0 | $400.00M | $128.00M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.